October 21, 2009 - SenoRx today announced that it ranked among the fastest growing companies in Deloitte's 2009 Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications and life sciences and clean technology companies in North America.

Rankings are based on percentage revenue growth during the five year period from 2004 to 2008. SenoRx grew 240 percent during this period, ranking it number 460 of the list.

Lloyd Malchow, SenoRx chairman and CEO, credits the significant progress that the company has made in creating a strong presence in the growing global market for interventional diagnostic and therapeutic products for breast care.

Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. This ranking is compiled from nominations submitted directly to the Technology Fast 500(TM) website, and public company database research conducted by Deloitte LLP. Technology Fast 500 award winners for 2009 are selected based on percentage fiscal year revenue growth during the five year period from 2004 to 2008.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or proprietary technology that contributes to a significant portion of the company's operating revenues. Using other companies' technology or intellectual property in a unique way does not satisfy this requirement. Consulting companies, professional service firms, etc. are not eligible unless they have proprietary technology that contributes to a significant portion of their operating revenues.

Technology Fast 500 award eligibility requirements include a base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, these revenues must have more than doubled between 2004 and 2008. Also companies must be in business for a minimum of five years, and be headquartered within North America.

For more information: www.senorx.com

Related Content

360 Photos | Brachytherapy Systems

This is a 360 degree view inside one of the brachytherapy treatment rooms at Northwestern Medicine's center in ...

Time October 28, 2021
arrow
News | Brachytherapy Systems

August 31, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

Time August 31, 2021
arrow
News | Radiation Oncology

June 2, 2021 — A breast cancer therapy that requires just one shot of radiotherapy is as effective as traditional ...

Time June 02, 2021
arrow
News | Brachytherapy Systems, Women's Healthcare

May 19, 2021 — A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells ...

Time May 19, 2021
arrow
News | Brachytherapy Systems

October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic ...

Time October 26, 2020
arrow
News | Brachytherapy Systems, Women's Healthcare

September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the ...

Time September 08, 2020
arrow
News | Brachytherapy Systems, Women's Healthcare

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation Therapy, makers of AccuBoost, announced the latest upgrades to the AccuBoost Digital platform. AccuBoost Digital leverages the Planmed Clarity digital mammography system to provide doctors with real-time image-guidance and targeting confidence in the delivery of accelerated partial breast irradiation (APBI) in patients opting for breast conserving therapy (BCT). These upgrades improve the treatment workflow, patient experience and user interface. By design, this non-invasive breast brachytherapy (NIBB) technique is 100 percent adaptive as each treatment fraction is assessed independently and is ideal for the challenges that APBI treatments can present.

Time October 23, 2019
arrow
Videos | Radiation Therapy

ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at the ...

Time February 21, 2019
arrow
News | Brachytherapy Systems, Women's Healthcare

Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent Electronic Brachytherapy (eBx) System were comparable to those seen in the TARGIT-A and ELIOT trials, according to new results. The results, published in the Annals of Surgical Oncology, came from a long-term study conducted at Hoag Memorial Hospital Presbyterian in Newport Beach, Calif.

Time January 07, 2019
arrow
News | Women's Health

Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to acquire Cianna Medical Inc., headquartered in Aliso Viejo, Calif. The deal structure includes an upfront payment of $135 million with potential earn-out payments of an additional $15 million for achievement of supply chain and scalability metrics, and up to an additional $50 million for achievement of sales milestones.

Time November 14, 2018
arrow
Subscribe Now